FDA Inspection 791890 — Oklahoma Blood Institute

Oklahoma Blood Institute — FEI 3008629186

The FDA completed an inspection of Oklahoma Blood Institute on July 19, 2012 in Fort Smith, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 19, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fort Smith, AR (United States)